ERGO.L
Price:
$1348
Market Cap:
$771.71M
Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, Asia, and Australia. It operates through two segments, Clinical Research Services and Pharmacovigilance. The company provides and manages clinical development, post-approval management, and pharmacovigilance services for pharmaceutical, biotechnology, and generics companies. It focuses on various therapeutic areas, including oncology, haematology, allergy, respiratory, and neurology/CNS, as well as develops orphan drugs. The company also provides site support s...[Read more]
Industry
Biotechnology
IPO Date
2014-07-15
Stock Exchange
LSE
Ticker
ERGO.L
According to Ergomed plc’s latest financial reports and current stock price. The company's current ROE is 19.71%. This represents a change of Infinity% compared to the average of 0% of the last 4 quarters.
The mean historical ROE of Ergomed plc over the last ten years is 4.22%. The current 19.71% ROE has changed 367.39% with respect to the historical average. Over the past ten years (40 quarters), ERGO.L's ROE was at its highest in in the January 2012 quarter at 0%. The ROE was at its lowest in in the January 2012 quarter at 0%.
Average
4.22%
Median
6.47%
Minimum
-31.66%
Maximum
18.85%
Discovering the peaks and valleys of Ergomed plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 144.93%
Maximum Annual ROE = 18.85%
Minimum Annual Increase = -1033.95%
Minimum Annual ROE = -31.66%
Year | ROE | Change |
---|---|---|
2022 | 17.68% | -6.21% |
2021 | 18.85% | 2.92% |
2020 | 18.31% | 21.09% |
2019 | 15.12% | -147.77% |
2018 | -31.66% | 144.93% |
2017 | -12.93% | -1033.95% |
2016 | 1.38% | -84.90% |
2015 | 9.16% | 143.19% |
2014 | 3.77% | 51.61% |
2013 | 2.49% | -97.76% |
The current ROE of Ergomed plc (ERGO.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
18.28%
5-year avg
7.66%
10-year avg
4.22%
Ergomed plc’s ROE is less than Volex plc (9.94%), less than Bioventix PLC (69.09%), less than Gamma Communications plc (16.09%), less than Kape Technologies PLC (6.97%), less than dotdigital Group Plc (11.80%),
Company | ROE | Market cap |
---|---|---|
9.94% | $498.47M | |
69.09% | $177.47M | |
16.09% | $1.40B | |
6.97% | $1.22B | |
11.80% | $256.83M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ergomed plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ergomed plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Ergomed plc's ROE?
How is the ROE calculated for Ergomed plc (ERGO.L)?
What is the highest ROE for Ergomed plc (ERGO.L)?
What is the 3-year average ROE for Ergomed plc (ERGO.L)?
What is the 5-year average ROE for Ergomed plc (ERGO.L)?
How does the current ROE for Ergomed plc (ERGO.L) compare to its historical average?